Kaplan-Meier survival curves indicated that pancreatic adenocarcinoma patients presenting concomitant high HDAC-1/HDAC-2 expression had significantly longer survival times compared to those with low expression (log-rank test, p = 0.0255). Here, HDAC2 is linked to pancreatic adenocarcinoma.